Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets

被引:15
作者
Pospieszna, Julia [1 ]
Dams-Kozlowska, Hanna [2 ,3 ]
Udomsak, Wachirawit [1 ]
Murias, Marek [1 ,4 ]
Kucinska, Malgorzata [1 ]
机构
[1] Poznan Univ Med Sci, Dept Toxicol, 30 Dojazd St,10 Uniwersytetu Poznanskiego St, PL-60631 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Canc Immunol, 15 Garbary St, PL-61866 Poznan, Poland
[3] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, 15 Garbary St, PL-61866 Poznan, Poland
[4] Adam Mickiewicz Univ, Ctr Adv Technol, Uniwersytetu Poznanskiego 10 St, PL-61614 Poznan, Poland
基金
英国科研创新办公室;
关键词
CD133; prominin-1; cancer stem cells; gene therapy; immunotherapy; nanotechnology; ANTI-CD133; MONOCLONAL-ANTIBODY; TUMOR-INITIATING CELLS; HEMATOPOIETIC STEM; SIGNALING PATHWAY; NEURAL STEM; LITHOCARPUS-POLYSTACHYUS; GOLD NANOPARTICLES; PROGENITOR CELLS; POOR-PROGNOSIS; GENE-TRANSFER;
D O I
10.3390/ijms241310910
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer remains a leading cause of death globally, and its complexity poses a significant challenge to effective treatment. Cancer stem cells and their markers have become key players in tumor growth and progression. CD133, a marker in various cancer types, is an active research area as a potential therapeutic target. This article explores the role of CD133 in cancer treatment, beginning with an overview of cancer statistics and an explanation of cancer stem cells and their markers. The rise of CD133 is discussed, including its structure, functions, and occurrence in different cancer types. Furthermore, the article covers CD133 as a therapeutic target, focusing on gene therapy, immunotherapy, and approaches to affect CD133 expression. Nanoparticles such as gold nanoparticles and nanoliposomes are also discussed in the context of CD133-targeted therapy. In conclusion, CD133 is a promising therapeutic target for cancer treatment. As research in this area progresses, it is hoped that CD133-targeted therapies will offer new and effective treatment options for cancer patients in the future.
引用
收藏
页数:29
相关论文
共 230 条
[121]   Signaling pathways in the regulation of cancer stem cells and associated targeted therapy [J].
Manni, Wang ;
Min, Wu .
MEDCOMM, 2022, 3 (04)
[122]   Cancer stem cell signaling pathways [J].
Matsui, William H. .
MEDICINE, 2016, 95 :S8-S19
[123]   A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning [J].
Miraglia, S ;
Godfrey, W ;
Yin, AH ;
Atkins, K ;
Warnke, R ;
Holden, JT ;
Bray, RA ;
Waller, EK ;
Buck, DW .
BLOOD, 1997, 90 (12) :5013-5021
[124]   Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors [J].
Mladinich, Megan ;
Ruan, Diane ;
Chan, Chia-Hsin .
STEM CELLS INTERNATIONAL, 2016, 2016
[125]   Gold nanoparticles conjugated with anti-CD133 monoclonal antibody and 5-fluorouracil chemotherapeutic agent as nanocarriers for cancer cell targeting [J].
Mohd-Zahid, Manali Haniti ;
Zulkifli, Siti Nadiah ;
Abdullah, Che Azurahanim Che ;
Lim, JitKang ;
Fakurazi, Sharida ;
Wong, Kah Keng ;
Zakaria, Andee Dzulkarnaen ;
Ismail, Norzila ;
Uskokovic, Vuk ;
Mohamud, Rohimah ;
Iskandar, Z. A. .
RSC ADVANCES, 2021, 11 (26) :16131-16141
[126]   Chronic myeloid leukemia stem cells: targeting therapeutic implications [J].
Mojtahedi, Hanieh ;
Yazdanpanah, Niloufar ;
Rezaei, Nima .
STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
[127]   Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 ( cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer [J].
Moon, Chang Mo ;
Kwon, Ji-Hee ;
Kim, Ji Suk ;
Oh, Sun-Hee ;
Lee, Kyoung Jin ;
Park, Jae Jun ;
Hong, Sung Pil ;
Cheon, Jae Hee ;
Kim, Tae Il ;
Kim, Won Ho .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (03) :519-529
[128]   Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer [J].
Moro, Massimo ;
Bertolini, Giulia ;
Pastorino, Ugo ;
Roz, Luca ;
Sozzi, Gabriella .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) :1027-1036
[129]   The hallmarks of ovarian cancer stem cells and niches: Exploring their harmonious interplay in therapy resistance [J].
Motohara, Takeshi ;
Yoshida, Go J. ;
Katabuchi, Hidetaka .
SEMINARS IN CANCER BIOLOGY, 2021, 77 :182-193
[130]   Cancer stem cell (CSC) resistance drivers [J].
Najafi, Masoud ;
Mortezaee, Keywan ;
Majidpoor, Jamal .
LIFE SCIENCES, 2019, 234